Steered molecular dynamics simulations reveal important residues for (un)binding of substrates, inhibitors and a product to the malarial M1 aminopeptidase.
Malaria is a life-threatening sickness unfold by mosquitoes. Plasmodium falciparum M1 alanyl aminopeptidase (PfM1-AAP) is a promising aim for the remedy of malaria. The simply recently solved crystal buildings of PfM1-AAP revealed that the buried full of life web page could also be accessed through two channel openings: a short N-terminal channel with th
e measurement of Eight Å and a protracted C-terminal channel with the scale of 30 Å. It is unclear, nonetheless, how substrates and inhibitors migrate to the full of life web page and a product of cleavage leaves.
Proper right here, we analysis the molecular mechanism of substrate and inhibitor migration to the full of life web page and the product launch using steered molecular dynamics simulations. We acknowledged a stepwise passage of substrates and inhibitors throughout the C-terminal channel of PfM1-AAP, involving (I) ligand recognition on the opening of the channel, (II) ionic translation to the ‘water reservoir’, (III) ligand reorientation throughout the ‘water reservoir’ and (IV) passage in an acceptable conformation into the full of life web page. Endorsed by enzymatic analysis of purposeful recombinant PfM1-AAP and mutagenesis analysis, our novel ligand-residue binding group analysis has acknowledged the purposeful residues controlling ligand migration all through the C-terminal channel of PfM1-AAP.
Furthermore, from unbinding simulations of the Arg product we advise a value repulsion as a result of the driving energy to expel the product out from the N-terminal channel of PfM1-AAP. Our work paves the best way by which within the path of the design of a novel class of PfM1-AAP inhibitors based mostly totally on stopping substrate entry to the full of life web page.
Rat Adenovirus (FL) Positive Control |
|||
MBS412080-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Rat Adenovirus (K87) Positive Control |
|||
MBS412081-1mL | MyBiosource | 1mL | EUR 175 |
Rat Adenovirus (K87) Positive Control |
|||
MBS412081-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Mouse Adenovirus (FL) Positive Control |
|||
MBS412078-1mL | MyBiosource | 1mL | EUR 175 |
Mouse Adenovirus (FL) Positive Control |
|||
MBS412078-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Mouse Adenovirus (K87) Positive Control |
|||
MBS412079-1mL | MyBiosource | 1mL | EUR 175 |
Mouse Adenovirus (K87) Positive Control |
|||
MBS412079-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Recombinant (E. Coli) Mouse Adenovirus (MADV) Hexon Protein (hxn) Control for Western Blot |
|||
MADV11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
CMV-Null control Adenovirus, in vivo ready |
|||
AVP-Null-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 346.5 |
Description: Pre-made Null-control Adenovirus, provided in PBS solution. |
Guinea Pig Adenovirus (FL/K87) Positive Control |
|||
MBS412059-1mL | MyBiosource | 1mL | EUR 175 |
Guinea Pig Adenovirus (FL/K87) Positive Control |
|||
MBS412059-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Adenovirus Rapid Test Control Pack (2 X 1.5mL) |
|||
KZMC035 | Zeptometrix | 2 X 1.5mL | EUR 59 |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus B], codon optimized for human cell expression, YP_002213798 |
|||
VC100290 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus B], codon optimized for human cell expression, YP_002213765 |
|||
VC100328 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus C], codon optimized for human cell expression, NP_040507 |
|||
VC100367 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus D], codon optimized for human cell expression, YP_001974422 |
|||
VC100424 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus E], codon optimized for human cell expression, YP_068018 |
|||
VC100462 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus F], codon optimized for human cell expression, NP_040845 |
|||
VC100500 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus B], codon optimized for human cell expression, YP_002213799 |
|||
VC100291 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus B], codon optimized for human cell expression, YP_002213800 |
|||
VC100292 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus B], codon optimized for human cell expression, YP_002213819 |
|||
VC100313 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus B], codon optimized for human cell expression, YP_002213826 |
|||
VC100314 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus B], codon optimized for human cell expression, YP_002213847 |
|||
VC100323 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus B], codon optimized for human cell expression, YP_002213766 |
|||
VC100329 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus B], codon optimized for human cell expression, YP_002213767 |
|||
VC100330 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus B], codon optimized for human cell expression, YP_002213786 |
|||
VC100350 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus B], codon optimized for human cell expression, YP_002213794 |
|||
VC100358 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus B], codon optimized for human cell expression, YP_002213836 |
|||
VC100362 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A 243R [Human adenovirus C], codon optimized for human cell expression, NP_040508 |
|||
VC100368 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus C], codon optimized for human cell expression, NP_040510 |
|||
VC100369 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus C], codon optimized for human cell expression, NP_040511 |
|||
VC100370 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus C], codon optimized for human cell expression, YP_001551768 |
|||
VC100390 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus C], codon optimized for human cell expression, NP_597753 |
|||
VC100396 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus C], codon optimized for human cell expression, NP_597755 |
|||
VC100400 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus D], codon optimized for human cell expression, YP_001974423 |
|||
VC100425 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus D], codon optimized for human cell expression, YP_001974446 |
|||
VC100426 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus D], codon optimized for human cell expression, YP_001974432 |
|||
VC100446 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus D], codon optimized for human cell expression, YP_001974464 |
|||
VC100453 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus D], codon optimized for human cell expression, YP_001974470 |
|||
VC100457 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus E], codon optimized for human cell expression, YP_068019 |
|||
VC100463 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus E], codon optimized for human cell expression, YP_068020 |
|||
VC100464 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus E], codon optimized for human cell expression, YP_068039 |
|||
VC100483 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus E], codon optimized for human cell expression, YP_068046 |
|||
VC100490 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus E], codon optimized for human cell expression, YP_068050 |
|||
VC100494 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus F], codon optimized for human cell expression, NP_040848 |
|||
VC100501 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus F], codon optimized for human cell expression, NP_040850 |
|||
VC100502 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus F], codon optimized for human cell expression, NP_040873 |
|||
VC100525 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus F], codon optimized for human cell expression, NP_040878 |
|||
VC100530 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus B], codon optimized for human cell expression, YP_002213848 |
|||
VC100324 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus B], codon optimized for human cell expression, YP_002213849 |
|||
VC100325 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus B], codon optimized for human cell expression, YP_002213850 |
|||
VC100326 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus B], codon optimized for human cell expression, YP_002213851 |
|||
VC100327 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus B], codon optimized for human cell expression, YP_002213837 |
|||
VC100363 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus B], codon optimized for human cell expression, YP_002213838 |
|||
VC100364 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus B], codon optimized for human cell expression, YP_002213839 |
|||
VC100365 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus B], codon optimized for human cell expression, YP_002213840 |
|||
VC100366 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus C], codon optimized for human cell expression, YP_001551773 |
|||
VC100401 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus C], codon optimized for human cell expression, NP_040534 |
|||
VC100402 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus C], codon optimized for human cell expression, YP_001551774 |
|||
VC100403 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus C], codon optimized for human cell expression, NP_597756 |
|||
VC100404 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus D], codon optimized for human cell expression, YP_001974471 |
|||
VC100458 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus D], codon optimized for human cell expression, YP_001974472 |
|||
VC100459 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus D], codon optimized for human cell expression, YP_001974473 |
|||
VC100460 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus D], codon optimized for human cell expression, YP_001974474 |
|||
VC100461 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus E], codon optimized for human cell expression, YP_068051 |
|||
VC100495 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus E], codon optimized for human cell expression, YP_068052 |
|||
VC100496 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus E], codon optimized for human cell expression, YP_068053 |
|||
VC100497 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus E], codon optimized for human cell expression, YP_068054 |
|||
VC100498 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus F], codon optimized for human cell expression, NP_040879 |
|||
VC100531 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus F], codon optimized for human cell expression, NP_040880 |
|||
VC100532 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus F], codon optimized for human cell expression, NP_040881 |
|||
VC100533 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus B], codon optimized for human cell expression, YP_002213846 |
|||
VC100322 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus B], codon optimized for human cell expression, YP_002213835 |
|||
VC100361 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus C], codon optimized for human cell expression, YP_001551772 |
|||
VC100399 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus D], codon optimized for human cell expression, YP_001974469 |
|||
VC100456 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus E], codon optimized for human cell expression, YP_068049 |
|||
VC100493 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus F], codon optimized for human cell expression, NP_040877 |
|||
VC100529 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Anti-Human Adenovirus Hexon Protein (hAd5 hxn) IgG negative control serum |
|||
950-110-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
Human Anti-Human Adenovirus Hexon Protein (hAd5 hxn) IgG positive control serum |
|||
950-110-02P | Alpha Diagnostics | 1 ml | EUR 270 |
Mouse Anti-Mouse Adenovirus Hexon Protein (MADV-hxn) IgG negative control serum |
|||
950-130-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular concentrating on, and synthetic and pure product CXCR4 inhibitors for many cancers treatment.
Chemokine 12 (CXCL12), usually generally known as stromal cell derived factor-1 (SDF-1) and a member of the CXC chemokine subfamily, is ubiquitously expressed in a number of tissues and cell varieties.
It interacts notably with the ligand for the transmembrane G protein-coupled receptors CXCR4 and CXCR7. The CXCL12/CXCR4 axis takes half in a sequence of physiological, biochemical, and pathological course of, akin to irritation and leukocyte trafficking, cancer-induced bone ache, and postsurgical ache, and likewise is a key problem throughout the cross-talking between tumor cells and their microenvironment.
Aberrant overexpression of CXCR4 is important for tumor survival, proliferation, angiogenesis, homing and metastasis. On this overview, we summarized the operate of CXCL12/CXCR4 in most cancers, CXCR4 inhibitors beneath scientific analysis, and pure product CXCR4 antagonists. In conclusion, the CXCL12/CXCR4 signaling is critical for tumor progress and concentrating on the pathway might symbolize an environment friendly technique to creating novel treatment in most cancers remedy
Affect on the mechanical properties of kind I collagen of intra-molecular lysine-arginine derived superior glycation end-product cross-linking.
Non-enzymatic superior glycation end product (AGE) cross-linking of collagen molecules has been hypothesised to result in necessary modifications to the mechanical properties of the connective tissues all through the physique, doubtlessly resulting in various age related sicknesses.
We now have investigated the impression of two of these cross-links, glucosepane and DOGDIC, on the tensile and lateral moduli of the collagen molecule through utilizing a steered molecular dynamics technique, using beforehand acknowledged preferential formation web sites for intra-molecular cross-links.
Our outcomes current that the presence of intra-molecular AGE cross-links will improve the tensile and lateral Youthful’s moduli throughout the low strain space by between 3.0-8.5% and a few.9-60.3% respectively, with little impression exhibited at better strains
Utility of FT/IR-ATR vibrational spectroscopy to reveal protein molecular building of feedstock and co-merchandise from Canadian and Chinese language language canola processing in relation to microorganism bio-degradation and enzyme bio-digestion.
The principal aim of this analysis was to make use of FT/IR-ATR vibrational spectroscopy to look at the connection between rumen dry matter (DM) and protein degradation, rumen undegraded protein (RUP) intestinal digestion and processing induced protein molecular building modifications in feedstock (canola oil seeds) and co-products (canola meal) from bio-oil processing from fully totally different crushing crops in Canada and China.
- The rumen DM and protein degradation, rumen undegraded protein intestinal digestion and protein molecular building affected by bio-oil processing have been examined using in situ, three step in vitro digestion and Fourier rework infrared (FT/IR) molecular spectroscopy methods, respectively. The outcomes confirmed that the protein molecular building; α-helix peak and α-helix to β-sheet peak ratio had an in depth affiliation with rumen DM and protein degradation and rumen undegraded protein intestinal digestibility.
- Quite a few regression analyses confirmed that protein β-sheet peak and α-helix to β-sheet peak ratio spectral depth could be utilized to predict rumen DM and protein degradation, whereas intestinal digestibility of rumen undegraded protein could also be predicted by α-helix peak and β-sheet peak.
- In conclusion, the co-product canola meal from bio-oil processing is an environment friendly provide of intestinally digestible protein. Rumen DM and protein degradation and intestinal digestibility of rumen undegraded protein are related to the protein molecular buildings of the co-products affected by modifications all through bio-oil processing
Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|||
0-120-0018 | Biologics | 25 mm | EUR 100 |
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
Titanium Cup Tip, 250 ml |
|||
0-120-0019 | Biologics | 250 ml | EUR 1377 |
Description: includes Interface Washers |
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
0-120-0021 | Biologics | each | EUR 113 |
Description: includes Interface Washers |
Continuous Flow Chamber |
|||
0-120-0026 | Biologics | each | EUR 774 |
Description: includes Interface Washers |
Interface Washers 1.5” Diameter, 5/Pkg |
|||
0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
0-120-0038 | Biologics | 1.5 ml | EUR 152 |
Description: Thermo conductive tube pods |
KoldPod, 15ml Conical Tube |
|||
0-120-0039 | Biologics | 15 ml | EUR 275 |
Description: Thermo conductive tube pods |
KoldPod, 50ml Conical Tube |
|||
0-120-0040 | Biologics | 50 ml | EUR 290 |
Description: Thermo conductive tube pods |
Model 150 V/T Ultrasonic Homogenizer |
|||
0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
Model 300 V/T Ultrasonic Homogenizer |
|||
0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
SONABOZ Sound Abating Chamber |
|||
0-125-0001 | Biologics | each | EUR 1020 |
Description: Reduces cavitational sound emitted during processing. |
Model 3000 Ultrasonic Homogenizer |
|||
0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
Model 3000MP Ultrasonic Homogenizer |
|||
0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
Peni Cylinder Dispenser with Manual Hopper |
|||
0-144-0002 | Biologics | each | EUR 5406 |
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
Stainless Steel Peni Cylinder with Flat Face |
|||
0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
Description: sold in packages of 100 pieces |
Stainless Steel Peni Cylinder with Chamfered Face |
|||
0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
Description: sold in packages of 100 pieces |
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
00002 | Biotium | 1UG | EUR 527 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-bungarotoxin, CF405s |
|||
00002 | Cusabio | 500uG | EUR 594 |
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
00002-100ug | Biotium | 100uG | EUR 132 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
9-00003 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
9-00003 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
9-00004 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
9-00004 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
9-00005 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
9-00005 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
9-00006 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
9-00006 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
9-00007 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
9-00007 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
9-00009 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
9-00009 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
Alpha-Bungarotoxin, 1 mg |
|||
00010-1 | Biotium | 1MG | EUR 193 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, 1 mg |
|||
00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
00011 | Biotium | 500uG | EUR 376 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
00012 | Biotium | 500uG | EUR 394 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
00013 | Biotium | 10ST | EUR 436 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
00014 | Biotium | 10ST | EUR 494 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
00015 | Biotium | 500uG | EUR 494 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
00016 | Biotium | 10ST | EUR 560 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
00017 | Biotium | 500uG | EUR 455 |
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
9-00018 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
9-00018 | Biotium |
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
Acrylamide, Chemzymes Ultra Pure® |
|||
00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
Description: 79-06-1 |
Acrylamide, Chemzymes Ultra Pure® |
|||
00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
Description: 79-06-1 |
Biotin-cAMP, 1 mg |
|||
00020 | Biotium | 1MG | EUR 298 |
Description: N/A |
Biotin-cAMP, 1 mg |
|||
00020-1 | Biotium | 20ST | EUR 298 |
Description: N/A |
Biotin-cAMP, 50 ug |
|||
00020-1-1 | Biotium | EA | EUR 414 |
Biotin-cGMP, 1 mg |
|||
00021 | Biotium | 1MG | EUR 331 |
Description: N/A |
Biotin-cGMP, 1 mg |
|||
00021-1 | Biotium | 20ST | EUR 331 |
Description: N/A |
Biotin-cGMP, 20x50 ug |
|||
00021-1-1 | Biotium | EA | EUR 447 |
Cyanine 644-cAMP, 1 mg |
|||
00022 | Biotium | 1MG | EUR 496 |
Description: N/A |
Cyanine 644-cAMP, 1 mg |
|||
00022-1 | Biotium | 20ST | EUR 496 |
Description: N/A |
Cyanine 644-cAMP, 20x50 ug |
|||
00022-1-1 | Biotium | EA | EUR 647 |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
00023 | Biotium | 1MG | EUR 285 |
Description: N/A |